As Medical affairs continues to prove a quickly evolving business and a prominent area of focus for many life sciences companies, keeping in pace with the increasing number of incoming investigator requests and regulatory guidelines is paramount. For GSK and many others involved in the business of approving and funding investigator initiated studies, the task of evaluating requests often presents numerous difficulties. Fostering positive communication with external investigators, delegating requests to appropriate subject matter experts, and tracking and reporting on key milestones is critical in the support of investigator initiated studies, which leaves no room for inefficiency.

For GSK ISS, process inefficiencies were growing as multiple systems and workflows were at play throughout the organization and across different therapeutic areas. Read how GSK standardized their process gaining both time and resource efficiency.

FREE DOWNLOAD